Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications
Open accessThe DOI matches its Crossref record; 186 of the 203 references it cites were found in a registry or an index.
Abstract
The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today. Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception. Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the molecular structure, general physiology, and pharmacology of distinct Nav channel subtypes. We discuss Nav channel ligands such as small molecules, toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody. Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit. Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clinical studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sodium channels are pseudo-heterotetrameric protein structures consisting of four highly similar domains, termed I, II, III, and IV (Figure 1). Each domain contains 6 membrane-spanning segments S1-S6 (Figure 1) [4] with S1-S4v forming the voltage-sensing domains and S5-S6 forming the pore loops and DEKA selectivity filter.”
From Progress in Understanding and Treating SCN2A-Mediated Disorders (2018) · cites this paper as [4]
Citations
Cites
1 retracted
Lee, J.-H., Park, C.-K., Chen, G., Han, Q., Xie, R.-G., Liu, T., Ji, R.-R., & Lee, S.-Y. (2014) · Cell · doi:10.1016/j.cell.2014.03.064 · Cited by 207
RetractedHodgkin, A. L., & Huxley, A. F. (1952) · The Journal of Physiology · doi:10.1113/jphysiol.1952.sp004764 · Cited by 23,191
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
The Economic Costs of Pain in the United States
Gaskin, D. J., & Richard, P. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2012.03.009 · Cited by 2,359
Catterall, W. A., Goldin, A. L., & Waxman, S. G. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.4 · Cited by 2,254
From Ionic Currents to Molecular Mechanisms
Catterall, W. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81133-2 · Cited by 2,118
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
An SCN9A channelopathy causes congenital inability to experience pain
Cox, J. J., Reimann, F., Nicholas, A. K., Thornton, G., Roberts, E., Springell, K., Karbani, G., Jafri, H., Mannan, J., Raashid, Y., et al. (2006) · Nature · doi:10.1038/nature05413 · Cited by 1,600
The crystal structure of a voltage-gated sodium channel
Payandeh, J., Scheuer, T., Zheng, N., & Catterall, W. A. (2011) · Nature · doi:10.1038/nature10238 · Cited by 1,429
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
Akopian, A. N., Souslova, V., England, S., Okuse, K., Ogata, N., Ure, J., Smith, A., Kerr, B. J., McMahon, S. B., Boyce, S., et al. (1999) · Nature Neuroscience · doi:10.1038/9195 · Cited by 816
Research works printed but not linked: 6
- Nardi, 2012, Advances in targeting voltage-gated sodium channels with small molecules, ChemMedChem, 7, 1
- Moreau, 2014, Biophysics, pathophysiology, and pharmacology of ion channel gating pores, Front. Pharmacol., 3, 5
- Cestèle, 2013, Nonfunctional Nav1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects, Proc. Natl. Acad. Sci. U. S. A., 110, 17546, 10.1073/pnas.1309827110 · DOI
- (a) Convergence Pharmaceuticals’ Novel Nav1.7 Selective Sodium Channel Blocker CNV1014802 Demonstrates Proof of Concept in Second Neuropathic Pain Study in Lumbosacral Radiculopathy; Convergence Pharmaceuticals: Cambridge, UK, Sept23, 2014; http://www.convergencepharma.com/userfiles/file/140923_LSR_FINAL.pdf, (accessed Mar 20, 2015).
- (b) The Pipeline; Convergence Pharmaceuticals: Cambridge, UK, 2015; http://www.convergencepharma.com/?page_id=16, (accessed Mar 20, 2015).
- Kwong, 2013, Pharmacological Characterization Of GSK2339345, A Novel Voltage-Gated Sodium Channel Blocker For The Symptomatic Relief Of Cough, Am J. Resp. Crit. Care Med., 187, A4936
Cited by
Items 201–300 of 603
Tao, H., Chen, X., Lu, M., Wu, Y., Deng, M., Zeng, X., Liu, Z., & Liang, S. (2015) · Toxicon · doi:10.1016/j.toxicon.2015.12.009 · Cited by 15
Ziki, M. D. A., Seidelmann, S. B., Smith, E., Atteya, G. A., Jiang, Y., Fernandes, R. G., Marieb, M. A., Akar, J. G., & Mani, A. (2017) · Clinical Genetics · doi:10.1111/cge.13036 · Cited by 15
Voltage-Gated Sodium Channels in Drug Discovery
Li, T., & Chen, J. (2018) · InTech eBooks · doi:10.5772/intechopen.78256 · Cited by 17
The Chemistry and Biology of the Tetrodotoxin Natural Product Family
Nißl, B., Muelbaier, M., Grisoni, F., Trauner, D. H., Bermúdez, M., Dialer, C., & Konrad, D. B. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202502404 · Cited by 21
Voltage-gated sodium channels in cancer and their specific inhibitors
Bian, Y., Tuo, J., He, L., Li, W., Li, S., Chu, H., & Zhao, Y. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154909 · Cited by 14
Anticonvulsant Classes and Possible Mechanism of Actions
Abd‐Allah, W. H., Anwar, M. A. E., Mohammed, E. R., & Moghazy, S. M. E. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00613 · Cited by 15
Differential roles of NaV1.2 and NaV1.6 in neocortical pyramidal cell excitability
Garcia, J. D., Wang, C., Alexander, R. P. D., Banks, E. R., Fenton, T., DeKeyser, J., Abramova, T. V., George, A. L., Ben‐Shalom, R., Hackos, D. H., et al. (2025) · eLife · doi:10.7554/elife.105696.3 · Cited by 14
The sorting receptor Rer1 controls Purkinje cell function via voltage gated sodium channels
Valkova, C., Liebmann, L., Krämer, A., Hübner, C. A., & Kaether, C. (2017) · Scientific Reports · doi:10.1038/srep41248 · Cited by 16
Fouillet, A., Watson, J. F., Piekarz, A. D., Huang, X., Li, B., Priest, B. T., Nisenbaum, E. S., Sher, E., & Ursu, D. (2017) · Molecular Pain · doi:10.1177/1744806917745179 · Cited by 14
Vidya, R., Talwar, R., Kanoje, V., Loriya, R., Banerjee, M., Patil, P. R., Joshi, A. A., Datrange, L., Das, A. K., Walke, D. S., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00361 · Cited by 14
Roecker, A. J., Layton, M. E., Pero, J. E., Kelly, M. J., Greshock, T. J., Kraus, R. L., Li, Y., Klein, R. M., Clements, M. K., Daley, C., et al. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00218 · Cited by 14
Self-citationDrug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary Mechanisms
Lou, S., & Cui, S. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210910124727 · Cited by 14
Changes in Biophysical Properties of Undifferentiated SH-SY5Y Cells During Long-term Cultures
Santillo, S. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.10.033 · Cited by 14
Yang, X., Ginjupalli, V. K. M., Thériault, O., Poulin, H., Appendino, J. P., Au, P. Y. B., & Chahine, M. (2022) · Journal of Neurophysiology · doi:10.1152/jn.00309.2021 · Cited by 14
Current and promising therapeutic options for Dravet syndrome
Riva, A., D’Onofrio, G., Amadori, E., Tripodi, D., Balagura, G., Iurilli, V., Vari, M. S., Verrottı, A., & Striano, P. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2127089 · Cited by 14
Wu, W., Yin, Y., Feng, P., Chen, G., Pan, L., Gu, P., Zhou, S., Lin, F., Ji, S., Zheng, C., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1067665 · Cited by 14
Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors
Wu, Y., Guernon, J. M., McClure, A. C., Venables, B. L., Rajamani, R., Robbins, K. J., Knox, R. J., Matchett, M., Pieschl, R. L., Herrington, J. B., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.01.035 · Cited by 16
General mechanism of spider toxin family I acting on sodium channel Nav1.7
Yuan, F., 湖南师范大学生命科学学院动物多肽药物创制国家地方联合工程实验室, 湖. 长., Sun, F., Zhang, L., Huang, B., An, H.-L., Rong, M., Du, C., 河北工业大学健康科学与生物医学工程学院生物物理研究所河北省分子生物物理重点实验室, 天. 3., & 成都佩德生物医药有限公司, 四. 成. (2022) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.185 · Cited by 14
Bigsby, S., NEAPETUNG, J. T., & Campanucci, V. A. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.994585 · Cited by 13
Thomas, C. F., Hawkins, D. Y., Skidanova, V., Marrujo, S. R., Gibson, J., Ye, Z., & Bradham, C. A. (2023) · Development · doi:10.1242/dev.201460 · Cited by 13
Pukkanasut, P., Whitt, J. D., Guenter, R. E., Lynch, S. E., Gallegos, C., Rosendo‐Pineda, M. J., Gómora, J. C., Chen, H., Lin, D. M., Sorace, A. G., et al. (2023) · Cancers · doi:10.3390/cancers15102806 · Cited by 13
Voltage-Gated Na+ Channels in Alzheimer’s Disease: Physiological Roles and Therapeutic Potential
Baumgartner, T. J., Haghighijoo, Z., Goode, N. A., Dvorak, N. M., Arman, P., & Laezza, F. (2023) · Life · doi:10.3390/life13081655 · Cited by 13
Neuronomodulation of Excitable Neurons
Chen, Y., Xiao, L., & Qiu, J. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01095-w · Cited by 13
Transmembrane Ion Channels: From Natural to Artificial Systems
Yan, T., & Liu, J. (2024) · Angewandte Chemie · doi:10.1002/ange.202416200 · Cited by 21
Dimerization mechanism of an inverted-topology ion channel in membranes
Ernst, M., Orabi, E. A., Stockbridge, R. B., Faraldo‐Gómez, J. D., & Robertson, J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2308454120 · Cited by 13
Sodium ion channels as potential therapeutic targets for cancer metastasis
Horne, J., Mansur, S., & Bao, Y. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.026 · Cited by 13
Current Pharmacologic Strategies for Treatment of Intractable Epilepsy in Children
Moon, J. U., & Cho, K. (2021) · International Neurourology Journal · doi:10.5213/inj.2142166.083 · Cited by 13
Anesthetic Mechanisms: Synergistic Interactions With Lipid Rafts and Voltage-Gated Sodium Channels
Krogman, W. L., Woodard, T., & McKay, R. S. F. (2023) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006738 · Cited by 12
Dissection of the structure–function relationship of Na v channels
Li, Z., Wu, Q., Huang, G., Jin, X., Li, J., Pan, X., & Yan, N. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2322899121 · Cited by 12
The discovery of a potent Na v 1.3 inhibitor with good oral pharmacokinetics
Pryde, D. C., Swain, N. A., Stupple, P. A., West, C. W., Marron, B. E., Markworth, C. J., Printzenhoff, D., Lin, Z., Cox, P. J., Suzuki, R., et al. (2017) · MedChemComm · doi:10.1039/c7md00131b · Cited by 12
Truncating tau reveals different pathophysiological actions of oligomers in single neurons
Hill, E., Karikari, T. K., Lantero‐Rodriguez, J., Zetterberg, H., Blennow, K., Richardson, M. J. E., & Wall, M. J. (2021) · Communications Biology · doi:10.1038/s42003-021-02791-x · Cited by 13
Russell, T., Gangotia, D., & Barry, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113850 · Cited by 12
Qin, H., Wei, A., Wang, Y., Wang, L., Xu, H., Yan, Z., Tian, X., Zheng, Y., Gao, Z., & Hu, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115371 · Cited by 12
5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel
Szanto, T. G., Fehér, Á. M., Korpos, É., Gyöngyösi, A., Kállai, J., Mészáros, B., Óvári, K. L., Lányi, Á., Panyi, G., & Varga, Z. (2023) · Pharmaceuticals · doi:10.3390/ph16050656 · Cited by 12
Mehrotra, S., Pierce, M. L., Cao, Z., Jabba, S. V., Gerwick, W. H., & Murray, T. F. (2022) · Journal of Natural Products · doi:10.1021/acs.jnatprod.1c01001 · Cited by 13
Pharmacodynamics—a pharmacognosy perspective
Campbell, J. E., Thomas-Brown, P. G., & Cohall, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18657-8.00025-6 · Cited by 12
Voltage-Gated Sodium Channel Inhibition by µ-Conotoxins
McMahon, K. L., Vetter, I., & Schroeder, C. I. (2024) · Toxins · doi:10.3390/toxins16010055 · Cited by 15
Huang, H., Wang, K., Liu, X., Wang, J., Suo, M., Liu, X., & Li, Z. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1397261 · Cited by 12
Exploration of the mechanism of action of cenobamate
Sankar, R., Ferrari, L., & Kamin, M. (2025) · Seizure · doi:10.1016/j.seizure.2025.11.010 · Cited by 12
Snake venom toxins targeting the central nervous system
Talukdar, A., Maddhesiya, P., Namsa, N. D., & Doley, R. (2022) · Toxin Reviews · doi:10.1080/15569543.2022.2084418 · Cited by 13
Romanova, D. Y., Balaban, P. M., & Nikitin, E. S. (2022) · Biophysica · doi:10.3390/biophysica2030019 · Cited by 12
Long-Term Blockade of Nociceptive Nav1.7 Channels Is Analgesic in Rat Models of Knee Arthritis
Reid, A. R., Côté, P. D., & McDougall, J. J. (2022) · Biomolecules · doi:10.3390/biom12111571 · Cited by 11
Elucidating molecular mechanisms of protoxin-II state-specific binding to the human NaV1.7 channel
Ngo, K., Mateos, D. L., Han, Y., Rouen, K. C., Ahn, S.-H., Wulff, H., Clancy, C. E., Yarov-Yarovoy, V. M., & Vorobyov, I. V. (2023) · The Journal of General Physiology · doi:10.1085/jgp.202313368 · Cited by 11
Boezio, A. A., Andrews, K. L., Boezio, C., Chu‐Moyer, M. Y., Copeland, K. W., DiMauro, E. F., Foti, R., Fremeau, R. T., Gao, H., Geuns-Meyer, S. D., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.04.035 · Cited by 11
Liu, Z., Wadsworth, P. A., Singh, A. K., Chen, H., Wang, P., Folorunso, O. O., Scaduto, P., Ali, S. R., Laezza, F., & Zhou, J. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.12.031 · Cited by 11
A Potential Mechanism of Sodium Channel Mediating the General Anesthesia Induced by Propofol
Xiao, J., Chen, Z., & Yu, B. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.593050 · Cited by 12
Comparison of Strategies to Overcome Drug Resistance: Learning from Various Kingdoms
Ogawara, H. (2018) · Molecules · doi:10.3390/molecules23061476 · Cited by 11
Abram, M., Jakubiec, M., Rapacz, A., Mogilski, S., Latacz, G., Szulczyk, B., Szafarz, M., Socała, K., Nieoczym, D., Wyska, E., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313092 · Cited by 11
Zhao, F., Fang, L., Wang, Q., Ye, Q., He, Y., Xu, W., & Song, Y. (2022) · Toxins · doi:10.3390/toxins15010033 · Cited by 10
Lin, Y., Tao, E., Champion, J. P., & Corry, B. (2023) · eLife · doi:10.7554/elife.91218 · Cited by 10
Williams, Z. J., Payne, L. B., Wu, X., & Gourdie, R. G. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.06.029 · Cited by 10
Xu, B., Zhang, R., Zhang, M., Chen, D., Zhang, Q., Zhang, N., Shi, Y., Hu, X., Li, N., & Fang, Q. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.12.012 · Cited by 10
Computational pipeline to probe NaV1.7 gain-of-function variants in neuropathic painful syndromes
Toffano, A., Chiarot, G., Zamuner, S., Marchi, M., Salvi, E., Waxman, S. G., Faber, C. G., Lauria, G., Giacometti, A., & Simeoni, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-74591-y · Cited by 11
Teneralli, R. E., Kern, D. M., Cepeda, M. S., Gilbert, J. P., & Drevets, W. C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.04.096 · Cited by 11
Wang, G., Wu, H., Wang, Y., Liu, X., Peng, S., Wang, W., Wu, M., Liu, Y., Wang, E., Wang, Z., et al. (2025) · Research · doi:10.34133/research.0599 · Cited by 10
Shioi, N., Nomura, S., Tanaka, Y., & Hirose, S. (2025) · Toxins · doi:10.3390/toxins17120579 · Cited by 9
Bimodal Imaging of Mouse Peripheral Nerves with Chlorin Tracers
Gonzales, J., Hernández‐Gil, J., Wilson, T. C., Adilbay, D., Cornejo, M., França, P. D. D. S., Guru, N., Schroeder, C. I., King, G. F., Lewis, J. S., et al. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00946 · Cited by 9
Jakubiec, M., Abram, M., Zagaja, M. P., Andres‐Mach, M., Szewczyk, A., Latacz, G., Szulczyk, B., Socała, K., Nieoczym, D., Właź, P., et al. (2022) · Cells · doi:10.3390/cells11121862 · Cited by 9
Treatment of status epilepticus: Physiology, pharmacology, and future directions
Sankar, R. (2023) · Epilepsia Open · doi:10.1002/epi4.12725 · Cited by 9
Discovery of a biarylamide series of potent, state-dependent NaV1.7 inhibitors
Schenkel, L. B., DiMauro, E. F., Nguyen, H. N., Chakka, N., Du, B., Foti, R., Guzmán-Pérez, A., Jarosh, M., La, D. S., Ligutti, J., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.06.054 · Cited by 9
Wang, J., Zheng, Y., Chen, Y., Gu, M., Gao, Z., & Nan, F. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0267-z · Cited by 9
Osorio-Méndez, D., Miller, A. H., Begeman, I. J., Kurth, A., Hagle, R., Rolph, D., Dickson, A. L., Chen, C., Halloran, M. C., Poss, K. D., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2200342119 · Cited by 9
Kawai, F. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00137.2023 · Cited by 9
Acaricide Resistance Monitoring and Structural Insights for Precision Tetranychus urticae Management
Kewedar, S., Chen, Q.-R., Moural, T. W., Lo, C., Umbel, E., Forrence, P. J., Walsh, D. B., & Zhu, F. (2025) · Insects · doi:10.3390/insects16050440 · Cited by 8
Molecular basis of sodium channel inactivation
Liu, Y., Galpin, J. D., Ahern, C. A., & Bezanilla, F. (2025) · Nature Communications · doi:10.1038/s41467-025-65587-1 · Cited by 11
Neurobiological activity of conotoxins via sodium channel modulation
Gallo, A., Boni, R., & Tosti, E. (2020) · Toxicon · doi:10.1016/j.toxicon.2020.08.019 · Cited by 8
Gene Expression at the Tripartite Synapse: Bridging the Gap Between Neurons and Astrocytes
Imrie, G., Gray, M. B., Raghuraman, V., & Farhy-Tselnicker, I. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-64839-7_5 · Cited by 8
Jiao, Y., Liu, J., Mao, W., Fang, R., Xia, T., Lang, Q., & Luo, T. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c00666 · Cited by 8
The role of ion channels in the regulation of dendritic cell function
Zhou, S.-L., Zhong, L., Wu, Y.-L., Ji, S.-W., Li, Y., & Niu, N. (2025) · Cell Calcium · doi:10.1016/j.ceca.2025.103031 · Cited by 9
Liu, H., Liu, Z., Zhou, H., Yan, R., Li, Y., Zhang, X., Bao, L., Yang, Y., Zhang, J., & Song, S. (2025) · BioChem · doi:10.3390/biochem5020018 · Cited by 9
Functionalized Fullerene Targeting Human Voltage-Gated Sodium Channel, hNav1.7
Hilder, T. A., Robinson, A., & Chung, S. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00099 · Cited by 8
Herrera‐Bravo, J., Farías, J. G., Contreras, F. P., Belén, L. H., & Beltrán, J. F. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105414 · Cited by 8
Ngum, N. M., Aziz, M. Y. A., Latif, L. M., Wall, R. J., Duce, I. R., & Mellor, I. R. (2022) · The Journal of Physiology · doi:10.1113/jp283055 · Cited by 8
Radiocaine: An Imaging Marker of Neuropathic Injury
Bartolo, N. D., Reid, S. E., Krishnan, H. S., Haseki, A., Renganathan, M., Largent‐Milnes, T. M., Norwood, B. A., Loggia, M. L., & Hooker, J. M. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00717 · Cited by 8
Dubey, N. K., Mishra, S., & Goswami, C. (2023) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2023.184178 · Cited by 8
The elusive Nav1.7: From pain to cancer
Banderali, U., Moreno, M., & Martina, M. (2023) · Current topics in membranes · doi:10.1016/bs.ctm.2023.09.003 · Cited by 8
Pharmacological Dissection of the Crosstalk between NaV and CaV Channels in GH3b6 Cells
Réthoré, L., Park, J., Montnach, J., Nicolas, S., Khoury, J., Seac’h, E. L., Mabrouk, K., de Pomyers, H., Tricoire-Leignel, H., Mattei, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020827 · Cited by 8
Todorov, P., Peneva, P., Georgieva, S., Tchekalarova, J. D., Rangelov, M. A., & Todorova, N. H. (2022) · New Journal of Chemistry · doi:10.1039/d1nj05235g · Cited by 8
Tramadol as a Voltage-Gated Sodium Channel Blocker of Peripheral Sodium Channels Nav1.7 and Nav1.5
Bok, C.-S., Kim, R.-E., Cho, Y., & Choi, J. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.002 · Cited by 9
Haustrate, A., Shapovalov, G., Spriet, C., Cordier, C., Kondratskyi, A., Noyer, L., Foulquier, F., Prevarskaya, N. B., & Lehen’kyi, V. (2023) · Cancers · doi:10.3390/cancers15061825 · Cited by 8
Discovery of new indole-based acylsulfonamide Nav1.7 inhibitors
Wu, Y., Venables, B. L., Guernon, J. M., Chen, J., Sit, S., Rajamani, R., Knox, R. J., Matchett, M., Pieschl, R. L., Herrington, J. B., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.12.013 · Cited by 9
Bioelectricity and excitable membranes
Aria, M. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817070-0.00001-4 · Cited by 8
Livshits, G., & Kalinkovich, A. (2021) · Pain Medicine · doi:10.1093/pm/pnab060 · Cited by 9
Suzetrigine: A novel selective sodium channel inhibitor for pain
Courtney, D., Potru, S., & Mathew, P. (2025) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaf219 · Cited by 7
Godad, A. P., Kelkar, S., Nailwal, N. P., Bhatia, N. Y., Doshi, G., & Sathaye, S. S. (2022) · Current Drug Targets · doi:10.2174/1389450123666220819141827 · Cited by 10
Phulera, S., Dickson, C. J., Schwalen, C. J., Khoshouei, M., Cassell, S. J., Sun, Y., Condos, T., Whicher, J. R., & Weihofen, W. A. (2024) · Structure · doi:10.1016/j.str.2024.07.021 · Cited by 7
From resting potential to dynamics: advances in membrane voltage indicators and imaging techniques
Shakibi, R., Yazdipour, F., Abadijoo, H., Manoochehri, N., Pouria, F. R., Bajooli, T., Simaee, H., Abdolmaleki, P., Khatibi, A., Abdolahad, M., et al. (2025) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583524000210 · Cited by 9
Voltage-Gated Sodium Channel β1 Gene: An Overview
Al-Ward, H., Liu, C., Liu, N., Shaher, F., Al‐Nusaif, M., Mao, J., & Xu, H. (2020) · Human Heredity · doi:10.1159/000516388 · Cited by 7
Ma, D., Wenqing, H., Chenguang, Y., Hu, S., Weijing, H., & Lü, Y. (2021) · Biophysics Reports · doi:10.52601/bpr.2021.210030 · Cited by 7
Hassan, M. T., Tayara, H., & Chong, K. T. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108737 · Cited by 7
Propofol binds and inhibits skeletal muscle ryanodine receptor 1
Joseph, T. T., Bu, W., Haji‐Ghassemi, O., Chen, Y. S., Woll, K. A., Allen, P. D., Brannigan, G. H., Petegem, F. V., & Eckenhoff, R. G. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.06.048 · Cited by 7
Domokos, D., Ducza, E., & Gáspár, R. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.11.017 · Cited by 7
Functional Characterization of the Nemertide α Family of Peptide Toxins
Jacobsson, E., Peigneur, S., Andersson, H. S., Laborde, Q., Strand, M., Tytgat, J., & Göransson, U. (2021) · Journal of Natural Products · doi:10.1021/acs.jnatprod.1c00104 · Cited by 7
Wang, G., Xu, L., Chen, H., Liu, Y., Pan, P., & Hou, T. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1641 · Cited by 7
Hernandez, J. S., Wainwright, M. L., & Mozzachiodi, R. (2017) · Learning & Memory · doi:10.1101/lm.044883.116 · Cited by 7
Permethrin induces epileptic susceptibility via activation of Na+ channels and rise in glutamate
Su, M., Zhang, Y., Feng, Z. G., Li, W., Liu, Y., Xu, C., Zhao, C., Kwan, P., Tian, X., & Li, L. (2025) · Communications Biology · doi:10.1038/s42003-025-09037-0 · Cited by 6
Assessing NaV1.7 during tonic firing in pig C-nociceptors
Soares, S. D. S., Schmelz, M., Carr, R. W., Sohns, K., & Rukwied, R. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335081 · Cited by 6
New aryl and acylsulfonamides as state-dependent inhibitors of Nav1.3 voltage-gated sodium channel
Zidar, N., Tomašič, T., Kikelj, D., Durcik, M., Tytgat, J., Peigneur, S., Rogers, M., Haworth, A. S., & Kirby, R. W. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115530 · Cited by 6
Capsaicin preferentially inhibits slow-inactivation sodium currents in insects
Kamezaki, M., & Nishiwaki, H. (2025) · Toxicon · doi:10.1016/j.toxicon.2025.108264 · Cited by 6
Traditional Chinese medicine treatment for epilepsy: Focusing on voltage-gated ion channels
Zhong, J., Zhang, M., Huang, S., Yao, J., Jiang, B., Gao, L., & Shi, Z.-G. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120129 · Cited by 6
Metadata
- Authors
- de Lera Ruiz, M., & Kraus, R. L.
- Affiliations
- Merck Research Laboratories , 770 Sumneytown Pike , , ,
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- ORCID
- Kraus, Richard L.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-04-30
- Volume
- 58
- Issue
- 18
- Pages
- 7093-7118
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2031713143
- Cited by
- 548
- References
- 203
- Citations by year
- 2026: 42 · 2025: 58 · 2024: 70 · 2023: 80 · 2022: 71 · 2021: 50 · 2020: 39 · 2019: 37 · 2018: 40 · 2017: 33 · 2016: 20 · 2015: 8
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Medicinal Chemistry (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- voltage-gated sodium channels, Nav1.7, sodium channel structure, sodium channel toxins, ligand binding sites, nociception, pain
- MeSH terms
- Animals, Biological Products, Cardiovascular Diseases, Clinical Trials as Topic, Drug Industry, Epilepsy, Humans, Ligands, Mutation, Neoplasms, Neuromuscular Diseases, Pain, Respiratory Tract Diseases, Ion Channel Gating, Protein Structure, Tertiary, Protein Subunits, Channelopathies, Voltage-Gated Sodium Channels, Voltage-Gated Sodium Channel Blockers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.